본문 바로가기
KERD
논문KCI 등재

Current status of acute myocardial infarction in Korea

김종진|안영근|정명호|김영조|조명찬|김용철
대한내과학회 (The Korean Association Of Internal Medicine)|2019.01|The Korean Journal of Internal Medicine|제34권 제1호|pp. 1-10|DOI https://doi.org/10.3904/kjim.2018.381

2

조회

0

다운로드

23

인용

0

참고문헌

키워드

MortalityMyocardial infarctionRisk factorsPrognosisPercutaneous coronary intervention
주제분류내과학

초록

Coronary artery disease, especially acute myocardial infarction (AMI), is a leading cause of death in the Asia-Pacific region. The Korea Acute Myocardial Infarction Registry (KAMIR) is the first nationwide, prospective, multicenter registry of Korean patients with AMI. Since the KAMIR first began in November 2005, more than 70,000 patients have been enrolled, and 230 papers have been published (as of October 2018). Moreover, published data from the KAMIR have revealed different characteristics from those of Western AMI registries regarding risk factors, interventional strategies, and clinical outcomes. As a result, the KAMIR study has improved the outcomes of percutaneous coronary intervention and reduced mortality. We propose the use of the KAMIR score in the prediction of 1-year mortality. Using data from the KAMIR, we provide an overview of the current status of AMI in Korea, including trends in demographic characteristics, risk factors, medications, treatment strategies, and clinical outcomes.

Abstract

Coronary artery disease, especially acute myocardial infarction (AMI), is a leading cause of death in the Asia-Pacific region. The Korea Acute Myocardial Infarction Registry (KAMIR) is the first nationwide, prospective, multicenter registry of Korean patients with AMI. Since the KAMIR first began in November 2005, more than 70,000 patients have been enrolled, and 230 papers have been published (as of October 2018). Moreover, published data from the KAMIR have revealed different characteristics from those of Western AMI registries regarding risk factors, interventional strategies, and clinical outcomes. As a result, the KAMIR study has improved the outcomes of percutaneous coronary intervention and reduced mortality. We propose the use of the KAMIR score in the prediction of 1-year mortality. Using data from the KAMIR, we provide an overview of the current status of AMI in Korea, including trends in demographic characteristics, risk factors, medications, treatment strategies, and clinical outcomes.

참고문헌 (51)

  1. Pacific 2016. Measuring Progress towards Universal Health Coverage, "Health at a Glance: Asia", pp.2016, OCED
  2. Kim Y, "The role of optical coherence tomography in the setting of acute myocardial infarction", J Cardiol, 72, pp.186~192 (2018)
  3. 심두선, "Differences in the Korea Acute Myocardial Infarction Registry Compared with Western Registries", Korean Circulation Journal, 47(6), pp.811~822 (2017), 대한심장학회[DOI]
  4. Kim Y, "Results of a 10-year experience in Korea using drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction(from the Korea Acute Myocardial Infarction Registry)", Am J Cardiol, 122, pp.365~373 (2018)
  5. Yeh RW, "Population trends in the incidence and outcomes of acute myocardial infarction", N Engl J Med, 362, pp.2155~2165 (2010)
  6. Puymirat E, "Acute myocardial infarction : changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI Program(French Registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction)1995 to 2015", Circulation, 136, pp.1908~1919 (2017)
  7. Jaffe AS, "It's time for a change to a troponin standard", Circulation, 102, pp.1216~1220 (2000)
  8. Antman EM, "Evaluation of a rapid bedside assay for detection of serum cardiac troponin T", JAMA, 273, pp.1279~1282 (1995)
  9. Apple FS, "Myocardial infarction redefined : role of cardiac troponin testing", Clin Chem, 47, pp.377~379 (2001)
  10. Rogers WJ, "Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006", Am Heart J, 156, pp.1026~1034 (2008)
  11. Taguchi E, "Impact of Killip classification on acute myocardial infarction : data from the SAIKUMA registry", Heart Vessels, 32, pp.1439~1447 (2017)
  12. Cambou JP, "The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction(FAST-MI) : study design and baseline characteristics", Arch Mal Coeur Vaiss, 100, pp.524~534 (2007)
  13. Hanssen M, "French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010 : FAST-MI 2010", Heart, 98, pp.699~705 (2012)
  14. Belle L, "French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data", Arch Cardiovasc Dis, 110, pp.366~378 (2017)
  15. 박혁진, "Blood Pressure Targets and Clinical Outcomes in Patients with Acute Myocardial Infarction", Korean Circulation Journal, 47(4), pp.446~454 (2017), 대한심장학회
  16. Lee SA, "Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients", Diabetes Care, 37, pp.2366~2373 (2014)
  17. 김경환, "Differential Benefit of Statin in Secondary Prevention of Acute Myocardial Infarction according to the Level of Triglyceride and High Density Lipoprotein Cholesterol", Korean Circulation Journal, 46(3), pp.324~334 (2016), 대한심장학회[DOI]
  18. Lee KH, "Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol", J Am Coll Cardiol, 58, pp.1664~1671 (2011)
  19. Ji MS, "Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis", Int J Cardiol, 225, pp.50~59 (2016)
  20. Chung SC, "Acute myocardial infarction : a comparison of short-term survival in national outcome registries in Sweden and the UK", Lancet, 383, pp.1305~1312 (2014)
  21. Kim HK, "Relationship between time to treatment and mortality among patients undergoing primary percutaneous coronary intervention according to Korea Acute Myocardial Infarction Registry", J Cardiol, 69, pp.377~382 (2017)
  22. Valgimigli M, "Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management : a randomized multicentre trial", Lancet, 385, pp.2465~2476 (2015)
  23. Valgimigli M, "Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome(MATRIX) : final 1-year results of a multicentre, randomised controlled trial", Lancet, 392, pp.835~848 (2018)
  24. Lee HW, "Comparison of transradial and transfemoral coronary intervention in octogenarians with acute myocardial infarction", Int J Cardiol, 202, pp.419~424 (2016)
  25. Ibanez B, "2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 39, pp.119~177 (2018)
  26. Neumann FJ, "2018 ESC", EACTS guidelines on myocardial revascularization, 2018, ~
  27. Park DW, "Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction", JAMA, 312, pp.2019~2027 (2014)
  28. Toma M, "Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction : insights from the APEX-AMI trial", Eur Heart J, 31, pp.1701~1707 (2010)
  29. Hannan EL, "Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease", JACC Cardiovasc Interv, 3, pp.22~31 (2010)
  30. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology(ESC), "ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation", Eur Heart J, 33, pp.2569~2619 (2012)
  31. American College of Emergency Physicians, "2013 ACCF", AHA guideline for the management of ST-elevation myocardial infarction : a report of the American College of Cardiology Foundation, J Am Coll Cardiol, pp.2013, 61[DOI]
  32. Wald DS, "Randomized trial of preventive angioplasty in myocardial infarction", N Engl J Med, 369, pp.1115~1123 (2013)
  33. Gershlick AH, "Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease : the CvLPRIT trial", J Am Coll Cardiol, 65, pp.963~972 (2015)
  34. Levine GN, "2015 ACC", AHA, AHA, pp.SCAI guideline for percutaneous coronary intervention and the 2013 ACCF, AHA guideline for the management of ST-elevation myocardial infarction[DOI]
  35. Kim MC, "Three-year clinical outcomes of staged, ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease", Int J Cardiol, 176, pp.505~507 (2014)
  36. 김인나, "Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease", Korean Circulation Journal, 47(1), pp.36~43 (2017), 대한심장학회
  37. Hong YJ, "The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction : results from Korea Acute Myocardial Infarction(KAMIR)", Int J Cardiol, 163, pp.1~4 (2013)
  38. Ahmed K, "Comparison of zotarolimus-and everolimus-eluting stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention", J Cardiol, 64, pp.273~278 (2014)
  39. Piao ZH, "Comparison of second-generation drug-eluting versus bare-metal stents in octogenarian patients with ST-segment elevation myocardial infarction", Int J Cardiol, 177, pp.1081~1084 (2014)
  40. Ji MS, "Comparison of Resolute zotarolimus-eluting stents versus everolimus-eluting stents in patients with metabolic syndrome and acute myocardial infarction : propensity score-matched analysis", Int J Cardiol, 199, pp.53~62 (2015)
  41. Kim Y, "Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: results from the Korea Acute Myocardial infarction Registry (KAMIR)", Cardiol J (2018)
  42. Szummer K, "Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments : experiences from the SWEDEHEART registry 1995-2014", Eur Heart J, 38, pp.3056~3065 (2017)
  43. Jeong HC, "Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonist", Int J Cardiol, 170, pp.291~297 (2014)
  44. Yang JH, "Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function:prospective cohort study", BMJ, 349, pp.g6650~ (2014)
  45. Valgimigli M, "2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS : the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for Cardio-Thoracic Surgery(EACTS)", Eur Heart J, 39, pp.213~260 (2018)
  46. Park KH, "Comparison of shortterm clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health", Int J Cardiol, 215, pp.193~200 (2016)
  47. Park KH, "Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization", J Cardiol, 71, pp.36~43 (2018)
  48. Kang J, "Third-generation P2Y12 inhibitors in East Asian acute myocardial infarction patients : a nationwide prospective multicentre study", Thromb Haemost, 118, pp.591~600 (2018)
  49. Kim MC, "Comparison of clinical outcomes between ticagrelor and prasugrel in patients with ST-segment elevation myocardial infarction : results from the Korea Acute Myocardial Infarction Registry-National Institutes of Health", Circ J, 82, pp.1866~1873 (2018)
  50. Kim HK, "A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction", Int J Cardiol, 145, pp.450~454 (2010)
  51. score), "Am J Cardiol", 2011, 965~971

관련 논문AI추천

The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry김영조, 김종진, 김현국, 심두선, 안영근, 이승훈, 정명호, 조명찬, 홍영준대한내과학회 · The Korean Journal of Internal Medicine2014 · 제29권 제6호Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020김민, 배장환, Kaneko Fumie, Kim Byeong-Keuk, Kim Eunji, Kim Hyeon Chang, Lee Hokyou, Lee Hyeok-Hee, Lee Seung-Jun, Moon Jenny, Seo Yeeun, Shin Sojung한국역학회 · Epidemiology and Health2024 · 제46권 Epidemiology of myocardial infarction in Korea: hospitalization incidence, prevalence, and mortality김장락, 황진용, Kim Rock Bum한국역학회 · Epidemiology and Health2022 · 제44권 Long-Term Clinical Outcomes according to Initial Management and Thrombolysis In Myocardial Infarction Risk Score in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction김영조, 김종진, 나승운, 류재영, 배장호, 성인환, 승기배, 안영근, 윤정한, 장양수, 정명호, 정욱성, 정해창, 조명찬, 조정관, 채성철, 채인호, 채제건, 최동훈, 허승호, 홍택종, Other Korea Acute Myocardial Infarction Registry Investigators연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제1호Different Impact of Diabetes Mellitus on In-hospital and 1-Year Mortality in Patients with Acute Myocardial Infarction Who Underwent Successful Percutaneous Coronary Intervention: Results from the Korean Acute Myocardial Infarction Registry김영조, 나승운, 박근호, 배장호, 성인환, 안영근, 장양수, 정명호, 조명찬, 채성철, 채제건, 허승호, 홍택종대한내과학회 · The Korean Journal of Internal Medicine2012 · 제27권 제2호Impact of guideline-directed medical therapy on the cardiac or non-cardiac death in acute myocardial infarctionDahee Hyun, Hyo-Soo Kim, Jin-Ho Choi, Myung Ho Jeong, Seung Ho Hur, Seung Jae Joo, Seung Woon Rha대한내과학회 · The Korean Journal of Internal Medicine2025 · 제40권 제5호

이 간행물의 다른 논문 (27건)

Update on heart failure management and future directions윤종찬, 박명수, 최홍미pp. 11-43Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure박성하pp. 44-49Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer안명주, 임성원pp. 50-59Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?차재명pp. 60-62Microbiological and genotypic factors affecting mortality in methicillin-resistant Staphylococcus aureus bacteremia주은정pp. 63-64
원문 보기